AI assistant
Sending…
Vitrolife — Major Shareholding Notification 2015
May 11, 2015
2989_iss_2015-05-11_3515d7c6-5eb9-4dc7-939e-8b041e91e1c0.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vitrolife AB
Holder
Nordea Funds Ab
Instrument
| Instrument | Ak SE0000816043 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,075,637 | |
| Voting rights | 1,075,637 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 08/05/2015 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,112,312 | |
| Directly held voting rights | 1,112,312 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 5.12 % | |
| Directly held voting rights | 5.12 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | ||
| Published | ||
| 11/05/2015 10:11 | ||
| Contact |
Name Göran Cnattingius
Phone +46733577412 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vitrolife
Board/Management Information
2026
May 22
Board/Management Information
2026
May 22
AGM Information
2026
May 5
AGM Information
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Board/Management Information
2026
Apr 1
Board/Management Information
2026
Apr 1
Annual Report
2026
Mar 26
Annual Report
2026
Mar 26